TRex Bio, Inc. (TRXB)
NASDAQ: TRXB · Real-Time Price · USD
14.25
+1.12 (8.53%)
Nov 11, 2026, 4:00 PM EST - Market closed
TRex Bio Employees
TRex Bio had 60 employees as of June 30, 2026. The number of employees increased by 6 or 11.11% since the number was reported on December 31, 2025. That makes TRex Bio the 34,211th largest employer in the world and 4,535th in the United States.
Employees
60
Change
6
Growth
11.11%
Revenue / Employee
n/a
Profits / Employee
-$773,200
Market Cap
383.64M
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 60 | 6 | 11.11% |
| Dec 31, 2025 | 54 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ARS Pharmaceuticals | 206 |
| C4 Therapeutics | 104 |
| Alector | 103 |
| Editas Medicine | 87 |
| Prelude Therapeutics | 79 |
| Altimmune | 57 |
| PepGen | 57 |
| Fennec Pharmaceuticals | 35 |
TRXB News
- 8 days ago - TRex Bio initiated with an Overweight at Cantor Fitzgerald - TheFly
- 8 days ago - TRex Bio initiated with an Overweight at JPMorgan - TheFly
- 9 days ago - TRex Bio initiated with a Buy at Stifel - TheFly
- 9 days ago - TRex Bio initiated with an Outperform at Wedbush - TheFly
- 4 weeks ago - TRexBio Announces Closing of Initial Public Offering - GlobeNewsWire
- 4 weeks ago - Opening Day: Biotech duo Retension, TRex Bio come public - TheFly
- 4 weeks ago - TRex Bio opens at $13.50, IPO priced at $14 per share - TheFly
- 4 weeks ago - TRex Bio indicated to open at $13.90, IPO priced at $14 - TheFly